In this episode of the No One Missed: Biomarker Testing in MBC series, patient advocate and podcast host, Jenny Burkholder and Dr. Mehta, MD, of MD Anderson Cancer Center, Dr. Mehta addresses the frustration many metastatic breast cancer patients experience when genomic testing doesn’t reveal actionable results, and why ongoing genomic testing remains crucial as clinical trials continue to explore new mutations and targeted therapies, potentially offering novel treatment options in the future.
About the No One Missed: Biomarker Testing in MBC series:
In this 10-episode video series, Jenny Burkholder, a metastatic breast cancer patient advocate and podcaster, sits down with Dr. Pallav Mehta, to discuss the importance of biomarker testing in metastatic breast cancer, including the science behind the powerful tool, and how it can improve patient outcomes.
Get the facts on biomarker testing for metastatic breast cancer and access resources to talk with your doctor about how this tool can help ensure you or your loved one's treatment plan is as effective as possible for metastatic breast cancer at: [ Ссылка ]
For more information from Living Beyond Breast Cancer about biomarker testing, visit: [ Ссылка ]
About the Video Series Hosts:
Jenny Burkholder is a metastatic breast cancer patient advocate and co-host of OVERexpressed & OUT podcast
Dr. Pallav Mehta, MD, is an Assistant Professor of Medicine, MD Anderson Cancer Center at Cooper and Medical Director at Reimagine Care
#metastaticbreastcancer #MBC #breastcancer #biomarkertesting #biomarkers
